Related Experiment Video
Updated: May 12, 2025

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
Clinical Profile of Polycystic Ovarian Syndrome in Women From Bhimavaram: A Cross-Sectional Study
Sri Chandana Mavulati1, Sujatha Dodoala2
1Pharmacology, Shri Vishnu College of Pharmacy, Bhimavaram, IND.
Abstract:
Introduction Polycystic ovarian syndrome (PCOS) is a complex endocrinological dysfunction that affects the hypothalamic-pituitary-ovarian axis. Despite its high prevalence, variations in phenotypic presentation and associated risk factors remain underexplored. The study aims to identify the prevalence, biochemical, clinical, and hormonal features of PCOS women, emphasizing phenotype classification and therapeutic interventions. Methods This cross-sectional, prospective multi-centre study was conducted in outpatient gynaecology clinics in Bhimavaram, India, from July 2019 to December 2023. Participants were diagnosed based on the Rotterdam criteria and classified into phenotypes A, B, C, and D. Data on socio-demographics, clinical manifestations, hormonal profiles, and treatment adherence were collected and analysed using Epi Info (version 7.2.6.0; Centers for Disease Control and Prevention, Atlanta, GA). Associations between phenotypes and metabolic profiles were assessed using analysis of variance (ANOVA) and chi-square tests. Results Among the study population, 403 (8.02%) were diagnosed with PCOS, with phenotype C in 139 (40.76%) being the most prevalent, followed by phenotypes D (n=90, 26.39%), A (n=89, 26.10%), and B (n=23, 6.74%), respectively. Oligomenorrhoea was a frequent menstrual disturbance found in 145 women (42.52%). Acne was experienced by 191 participants (56.01%), and hirsutism was seen in 182 (53.32%), signifying them as common hyperandrogenic symptoms. It is also noted that a significant proportion of the study population was overweight or obese (n=162, 47.5%). Anaemia was observed in 268 participants (78.6%), while 71 (20.82%) women had hypothyroidism, and 14 (4.11%) were diabetic. Therapeutic management included clomiphene citrate, hormonal contraceptives, and metformin. However, adherence remained a key challenge in achieving therapeutic success. Conclusion With the increase in the prevalence rate, early diagnosis and lifestyle modifications are required to prevent long-term complications in women. Additionally, risk factors identified in this study can be modified with appropriate interventions and preventive measures.

